The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
ACPred-Fuse: fusing multi-view information improves the prediction of anticancer peptides
Abstract
Fast and accurate identification of the peptides with anticancer activity potential from large-scale proteins is currently a challenging task. In this study, we propose a new machine learning predictor, namely, ACPred-Fuse, that can automatically and accurately predict protein sequences with or without anticancer activity in peptide form. Specifically, we establish a feature representation learning model that can explore class and probabilistic information embedded in anticancer peptides (ACPs) by integrating a total of 29 different sequence-based feature descriptors. In order to make full use of various multiview information, we further fused the class and probabilistic features with handcrafted sequential features and then optimized the representation ability of the multiview features, which are ultimately used as input for training our prediction model. By comparing the multiview features and existing feature descriptors, we demonstrate that the fused multiview features have more discriminative ability to capture the characteristics of ACPs. In addition, the information from different views is complementary for the performance improvement. Finally, our benchmarking comparison results showed that the proposed ACPred-Fuse is more precise and promising in the identification of ACPs than existing predictors. To facilitate the use of the proposed predictor, we built a web server, which is now freely available via http://server.malab.cn/ACPred-Fuse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Wei, L., Xing, P., Zeng, J., Chen, J., Su, R., & Guo, F. (2017) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2017.03.001 · Cited by 242
Self-citationSu, R., Wu, H., Xu, B., Liu, X., & Wei, L. (2019) · IEEE/ACM Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2018.2858756 · Cited by 134
Self-citationCancer Diagnosis Through IsomiR Expression with Machine Learning Method
Liao, Z., Li, D., Wang, X., Li, L., & Zou, Q. (2018) · Current Bioinformatics · doi:10.2174/1574893611666160609081155 · Cited by 130
Cited by
AntiCP 2.0: an updated model for predicting anticancer peptides
Agrawal, P., Bhagat, D., Mahalwal, M., Sharma, N., & Raghava, G. P. S. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa153 · Cited by 345
Machine intelligence in peptide therapeutics: A next‐generation tool for rapid disease screening
Basith, S., Manavalan, B., Hwan Shin, T., & Lee, G. (2020) · Medicinal Research Reviews · doi:10.1002/med.21658 · Cited by 312
Bridging machine learning and peptide design for cancer treatment: a comprehensive review
Rezaee, K., & Eslami, H. (2025) · Artificial Intelligence Review · doi:10.1007/s10462-025-11148-3 · Cited by 34
Metadata
- Authors
- Rao, B., Zhou, C., Zhang, G., Su, R., & Wei, L.
- Venue
- Briefings in Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-11-12
- Volume
- 21
- Issue
- 5
- Pages
- 1846-1855
- ISSN
- 1467-5463 (ISSN-L)
- 1477-4054
- OpenAlex
- W2987660980
- Cited by
- 179
- References
- 5
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ACPred-Fuse: fusing multi-view information improves the prediction of anticancer peptides. https://app.cochat.ai/papers/10.1093/bib/bbz088
- The paper
- Rao, B., Zhou, C., Zhang, G., Su, R., & Wei, L. (2020). ACPred-Fuse: fusing multi-view information improves the prediction of anticancer peptides. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbz088
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.